These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5833977)

  • 1. [Clinical research on the therapeutic activity of an antitoxic aminoacid-factor complex in neuropsychic syndromes due to hepatic insufficiency].
    Parravicini M; Salmini G
    Gazz Med Ital; 1965 Jul; 124(7):214-23. PubMed ID: 5833977
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of the intravenous administration of a combination of amino acids and of an antitoxic liver extract].
    Malvicini G; Tinozzi S
    Minerva Med; 1968 Mar; 59(19):1027-33. PubMed ID: 5646216
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic effect of a preparation of total liver extract, cyanocobalamin and amino acids of the Krebs cycle, in acute and chronic liver diseases].
    Pignattari S; Sarti F; Toscano S; Dal Monte PR
    Minerva Med; 1972 Jul; 63(53):2861-72. PubMed ID: 5049878
    [No Abstract]   [Full Text] [Related]  

  • 4. [On 30 cases of moderate hepatic insufficiency treated with the combination of diisopropylammonium dichloroethanoate, antitoxic hepatic extract and B complex].
    Gambini G; Manganaro M
    Arch Ital Sci Med Trop Parassitol; 1965; 46(9):359-62. PubMed ID: 5853821
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effectiveness of ampevit in incipient forms of cerebral atherosclerosis according to manifestations of the bioelectrical activity of the brain].
    Belonog RP; Karaban' IN
    Vrach Delo; 1977 Nov; (11):76-9. PubMed ID: 595567
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatoprotective & antitoxic activity of a liver extract combined with B complex; clinical & experimental study].
    BELLELLI L
    Minerva Med; 1958 Feb; 49(14):545-50. PubMed ID: 13541034
    [No Abstract]   [Full Text] [Related]  

  • 7. [Protection of the liver in anti-mycobacterial treatments].
    Serra C
    Omnia Med Ther; 1967; 45(2):449-544. PubMed ID: 4235621
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical research on the hepatoprotective and antianemic action of hepatic opotherapy associated with nucleosides in high doses].
    Bestagno M
    Arch Maragliano Patol Clin; 1966; 22(3):299-309. PubMed ID: 5953073
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinico-morphological characteristics of cerebrovascular disorders in hepatic insufficiency].
    Martynov IuS; Malkova EV
    Klin Med (Mosk); 1970 May; 48(5):61-7. PubMed ID: 5434074
    [No Abstract]   [Full Text] [Related]  

  • 10. [The role of serum proteins in the origin of the neuropsychic syndrome during chronic hepatopathies; their chromatographic separation].
    Mardare G; Strat C; Drăgan M; Russu G; Boingeanu A; Stanciu C; Triandaf N
    Med Interna (Bucur); 1970 Jan; 22(1):115-24. PubMed ID: 5527980
    [No Abstract]   [Full Text] [Related]  

  • 11. [Considerations on the therapy of viral hepatitis].
    Moggi C; Frangini V
    Clin Ter; 1968 Dec; 47(5):477-83. PubMed ID: 5706853
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatics. 51].
    Richter J; Kny L; Gerecke K
    Pharm Prax; 1971; 3():49-72. PubMed ID: 4397834
    [No Abstract]   [Full Text] [Related]  

  • 13. [Slight hepatic insufficiency].
    BASILE RC
    An Paul Med Cir; 1954 Jan; 67(1):9-26. PubMed ID: 13171571
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic activity in the geriatric age of hepatic opotherapy in association with high doses of nucleosides].
    Baldoni E; Floris E; Serenthà P; Negri U; Nuzzo L
    G Gerontol; 1968 Nov; 16(11):1261-99. PubMed ID: 5731973
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatic encephalopathy: comparative study of EEG abnormalities, neuropsychic disturbances and blood ammonia.
    Demedts M; Pillen E; De Groote J; Van de Woestijne KP
    Acta Neurol Belg; 1973; 73(5):281-8. PubMed ID: 4785018
    [No Abstract]   [Full Text] [Related]  

  • 16. [Trial of LL 650 in various hepatic diseases].
    Savoye B; Dietsch R; Chapuy M; Girard M
    J Med Lyon; 1972 May; 53(228):675-6 passim. PubMed ID: 5084113
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nutramin C Spofa in treatment of hepatic encephalopathy and hepatic coma].
    Vavros B; Kruf M
    Vnitr Lek; 1977 Jun; 23(6):597-608. PubMed ID: 883136
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical trial of liver-protective agents containing cytidine and uridine in the therapy of patients with liver diseases].
    Grimaldi N; Santoro C
    Policlinico Med; 1971; 78(3):134-46. PubMed ID: 5568445
    [No Abstract]   [Full Text] [Related]  

  • 19. [Trofopar treatment of chronic diffuse diseases of the liver].
    Loginov AS; Nikolaeva AP; Bendikov EA; Blok IuE; Sukhareva GV
    Sov Med; 1989; (7):79-81. PubMed ID: 2799537
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepason in the treatment of hepatocellular diseases].
    Stazka Z; Korolko A
    Pol Tyg Lek; 1970 Jul; 25(28):1062-4. PubMed ID: 5451158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.